Analysis of transcriptomic data overall showed that prognostic and molecular relationships of CD73 change dramatically with changing immune and stromal cell levels in the tumor microenvironment in silico, which may explain its contrasting tumor-suppressor-like relationships in vitro compared to associations with poor prognosis in patient tumors. Here, NT5E is linked to neoplasm.